Definitions and Miscellaneous Provisions. (i) GSK shall continue to make each annual listing and the most recent quarterly listing of Payments available on its website during the term of the CIA. GSK shall retain and make available to OIG, upon request, all supporting documentation, correspondence, and records related to all applicable Payments and to the annual and/or quarterly listings of Payments. Nothing in this Section III.O affects the responsibility of GSK to comply with (or liability for noncompliance with) all applicable Federal health care program requirements and state laws as they relate to all applicable Payments made to physicians or Related Entity.
(ii) For purposes of Section III.O.1, “Payments” is defined to include all “payments or other transfers of value” as that term is defined in §1128G(e)(10) under Section 6002 of the Affordable Care Act and any regulations promulgated thereunder. The term Payments includes, by way of example, the types of payments or transfers of value enumerated in §1128G(a)(1)(A)(vi) of the Affordable Care Act. The term includes all payments or transfers of value made to Related Entities on behalf of, at the request of, for the benefit or use of, or under the name of a physician for whom GSK would otherwise report a Payment if made directly to the physician. The term Payments also includes any payments or transfers of value made, directly by GSK or by a vendor retained by GSK to a physician or Related Entity in connection with, or under the auspices of, a co-promotion arrangement. GlaxoSmithKline LLC Corporate Integrity Agreement
Definitions and Miscellaneous Provisions. The following definitions and miscellaneous provisions shall apply under this Agreement:
Definitions and Miscellaneous Provisions. For the purposes of this Agreement only, the following definitions shall apply:
Definitions and Miscellaneous Provisions. A. If any provision of this Agreement or any application of this Agreement to any Employee or group of Employees shall be found contrary to law, such provision or application shall not be deemed valid and subsisting except to the extent permitted by law. All other provisions of this Agreement shall remain in full force and effect.
B. In case school is canceled due to an act of God, Employees are not expected to report for work, intent being when students will be in attendance. In the event school is canceled after Employees have reported for work, the Employees will remain on the job until released by the Superintendent, intent being the effect of a smooth closing of the buildings. If the District is required to make up a day(s) that school was closed in order to receive full state aid, the member(s) will work the rescheduled day at no extra compensation as the member will have previously been paid.
Definitions and Miscellaneous Provisions. Any capitalized term used but not otherwise defined in this Note shall have the definition given such term as set forth in the Purchase Agreement, which definition is, to the extent applicable, incorporated herein by reference. The provisions of Section 12 of the Purchase Agreement are applicable to this Note and are incorporated herein by reference.
Definitions and Miscellaneous Provisions. The terms "Makers", "
Definitions and Miscellaneous Provisions. The following definitions and miscellaneous provisions shall apply under this Trust Agreement:
Definitions and Miscellaneous Provisions. In these terms and conditions, “Agreement” means the agreement or order to which these terms and conditions are appended or in which they are incorporated by reference. Terms and conditions on Customer’s purchase orders will have no effect.
Definitions and Miscellaneous Provisions. (i) AstraZeneca shall continue to make each annual listing and the most recent six-month or quarterly listing of Payments available on its website at least throughout the term of this CIA. AstraZeneca shall retain and make available to OIG, upon request, all relevant business records sufficient to demonstrate the purpose of the Payment and (where applicable) the performance of a service by the HCP related to all applicable Payments and to the annual, six-month, and/or quarterly listings of Payments. Nothing in this Section III.M affects the responsibility of AstraZeneca to comply with (or liability for noncompliance with) all applicable Federal health care program requirements and state laws as they relate to all applicable Payments made to physicians or Related Entities.
(ii) For purposes of Section III.M.1, the term “Phase I Payments” is defined as all fees paid in connection with U.S.-based physicians serving as promotional speakers in the United States or participating in prerequisite speaker training for such promotional speaker engagements.
Definitions and Miscellaneous Provisions. (i) J&J shall continue to ensure that each annual listing and the most recent quarterly listing of Payments are available on its own website (through a link or other appropriate means) and the J&J Pharmaceutical Affiliates’ respective websites during the term of the CIA. J&J and/or the applicable J&J Pharmaceutical Affiliates shall retain and make available to OIG, upon request, all supporting documentation, correspondence, and records related to all applicable Payments and to the annual and/or quarterly listings of Payments. Nothing in this Section III.N affects the responsibility of J&J and/or any J&J Pharmaceutical Affiliate to comply with (or liability for noncompliance with) all applicable Federal health care program requirements and state laws as they relate to all applicable Payments made to physicians or Related Entity.
(ii) For purposes of Section III.N.1, “Payments” is defined to include all “payments or other transfers of value” as that term is defined in §1128G(e)(10) under Section 6002 of the Affordable Care Act and any regulations promulgated thereunder. The term Payments includes, by way of example, the types of payments or transfers of value enumerated in §1128G(a)(1)(A)(vi) of the Affordable Care Act. The term includes all payments or transfers of value made to Related Entities on behalf of, at the request of, for the benefit or use of, or under the name of a physician for whom a J&J Pharmaceutical Affiliate would otherwise report a Payment if made directly to the physician. The term Payments also includes any payments or transfers of value made, directly by a J&J Pharmaceutical Affiliate or by a vendor retained by a J&J Pharmaceutical Affiliate to a physician or Related Entity in connection with, or under the auspices of, a co-promotion arrangement.
